Rankings
▼
Calendar
XNCR Q3 2017 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$861M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
-9.3% YoY
Gross Profit
-$12M
-173.7% margin
Operating Income
-$16M
-232.6% margin
Net Income
-$16M
-219.5% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
-46.9%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$7M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$398M
Total Liabilities
$108M
Stockholders' Equity
$291M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$8M
-9.3%
Gross Profit
-$12M
-$6M
-97.2%
Operating Income
-$16M
-$9M
-78.2%
Net Income
-$16M
-$8M
-92.7%
← FY 2017
All Quarters
Q4 2017 →